New Century Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-273
Closed -$208K 35
2025
Q3
$208K Sell
273
-172
-39% -$128K 0.37% 60
2025
Q2
$347K Buy
+445
New +$346K 0.41% 62
2025
Q1
Sell
-2,823
Closed -$2.21M 239
2024
Q4
$2.21M Sell
2,823
-234
-8% -$194K 0.94% 16
2024
Q3
$2.71M Buy
3,057
+872
+40% +$784K 0.99% 15
2024
Q2
$1.98M Buy
2,185
+199
+10% +$159K 0.84% 20
2024
Q1
$1.55M Buy
1,986
+780
+65% +$555K 1.07% 14
2023
Q4
$703K Buy
+1,206
New +$704K 0.61% 55

Other funds holding LLY

New Century Financial Group's LLY Position: Q4 2025 in Review

New Century Financial Group sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 273 shares — an estimated $208K sold.

New Century Financial Group first reported a position in LLY in Q4 2023 and held it in 7 quarters. The position peaked at $2.71M in Q3 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • New Century Financial Group reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • New Century Financial Group sold 273 Eli Lilly shares in Q4 2025, an estimated $208K.
  • New Century Financial Group first reported a position in Eli Lilly in Q4 2023 and held it in 7 quarters.
  • New Century Financial Group's Eli Lilly position peaked at $2.71M in Q3 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on New Century Financial Group's 13F filing for Q4 2025.